ArticleJournal of Crohn's & colitis2018

Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease.

Konstantinos Papamichael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.